Clinical Supply Manufacturing

Providing Analytical method development, validation and stability study from Phase I-III to commercial prodcution and registration.

FDA approved facility in China providing Contract Development and Manufacturing Services in Various Dosage Forms: • Tablets • Capsules • Granules/Powder for OS • Oral Solutions • Drops • Ointment • Cream • Gel

Applicable for most generics/OTCs and innovative drugs.

Standards: • US, EU, China, WHO Commercial Scales
• Tablets: 3 billion/year • Capsules: 500 million/year • Oral solution: 100 million/year • Ointment: 50 million/year • Granules: 300 million/year

NCEs • Phase I-III formulation and development Generic Drugs • Pharmaceutical, analytical method development and process study

Metoprolol Succinate Extended-Release Tablets is a beta 1-selevitve adrenoceptor blocking agent, which can  reduce heart rate, myocardial contractility, blood pressure, antagonize the toxicity of catecholamine adreneric transmitters, and has good cardiovascular protection. It is widely used in cardiov...

For the treatment of Major Depressive Disorder (MDD), Panic Disorder (PD), Social Anxiety Disorder (SAD) and Premenstrual Dysphoric Disorder (PMDD).